Sputtr.com | Alternative Search Engine

Opioid

Opioid Intolerance Decision Algorithm

( Detail-Document #220201: Page 4 of 4) References 1. Gilbar PJ, Ridge AM. Inappropriate labeling of patients as opioid allergic. J Oncol Pharm Practice 2004;10:177-82.

Opioids for persistent pain: Information for patients

This leaflet can help you understand your pain problem and also help you to work with your health-care team to decide if you would like to try opioid treatment.

OPIOID EDUCATION PROGRAM

OPIOID EDUCATION PROGRAM FALL 2006 Chicago: Sept. 16 - 17 Philadelphia: Oct. 7 - 8 Miami: Oct. 28 - 29 Houston: Nov. 11 - 12 This intensive, 2-day program, led by a renowned group of specialists, is designed to inform primary care physicians, pain specialists, pharmac ists, and other opioid ...

Opioid Withdrawal Protocol – January 2010

Mental Health and Addiction Services: Brief/Social Detox Unit Developed by: Dr, Peter Butt MD SCFP (EM), Melanie McLeod BSP, ACPR, PharmD Candidate, Christi Becker-Irvine RN 1 OPIOID WITHDRAWAL PROTOCOL Clinical Features of Opioid Withdrawal - detected & monitored using the Opioid Withdrawal ...

OPIOID AGREEMENT

Jay A. Hendrickson, M.D. Brian Kelly Hunt, M.D. 2575 E. Bidwell Street, Suite 230, Folsom, CA 95630 Phone: (916) 984-3899 Fax: (916) 984-6522 OPIOID AGREEMENT 1.

Opioid Management Reference

Equianalgesic Dose Conversion Guide This guide illustrates one method of changing from one opioid or route of administration to another. Clinicians must be able to identify appropriate opioid doses when a patient requires a change of opioid and/or route of administration.

Guidelines for the Psychosocially Assisted Pharmacological ...

Book design by Zando Escultura Printed in WHO Library Cataloguing-in-Publication Data Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence. 1.Opioid-related disorders - drug therapy. 2.Opioid-related disorders - psychology. 3.Substance abuse - prevention and control ...

Opioid Therapy for Chronic Pain

FDA Warnings/Regulatory Alert Subsequent to CPG Completion FDA has issued the following important revised regulatory and/or warning: Drug Withdrawal November 19, 2010 - Propoxyphene (Darvon, Darvocet): Xanodyne Pharmaceuticals has agreed to withdraw propoxyphene, an opioid pain reliever used to ...

The content printed in this guide has been distributed ...

increasedmarkedly. 20,37 Cautious, Evidence-Based Opioid Prescribing PHYSICIANS FOR RESPONSIBLE OPIOID PRESCRIBING www.responsibleopioidprescribing.org

Opioid Induced Hyperalgesia: Clinical Implications for the ...

Opioids have been and continue to be used for the treatment of chronic pain. Evidence supports the notion that opioids can be safely administered in patients with chronic pain without the development of addiction or chemical dependency.